Hujia Shen

Phosphorylated ERK is a potential predictor of sensitivity to sorafenib when treating hepatocellular carcinoma: evidence from an in vitro study

Zhe Zhang, Zhe Zhang, Xiaoping Zhou, 2009, BMC medicine.